Skip to content

Clinical trials

Completed Myeloproliferative Disorders trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Status: Completed Country / region: Germany Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20041
20052
20061
20091
20101
20112
20121
20132
20144
20151
20171
20181
20192
20202
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center5
Novartis Pharmaceuticals4
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS3
European Organisation for Research and Treatment of Cancer - EORTC2
Incyte Corporation2
AOP Orphan Pharmaceuticals AG1
Celgene1
Constellation Pharmaceuticals1
Epizyme, Inc.1
Italfarmaco1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders25
Leukemia, Myeloid, Acute10
Polycythemia Vera9
Primary Myelofibrosis9
Bone Marrow Diseases7
Hematologic Diseases7
Precursor Cell Lymphoblastic Leukemia-Lymphoma7
Hodgkin Disease6
Leukemia, Lymphocytic, Chronic, B-Cell6
Lymphoma, Large B-Cell, Diffuse6

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.